SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-213436
Filing Date
2023-08-15
Accepted
2023-08-15 16:05:29
Documents
12
Period of Report
2023-08-11
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d493024d8k.htm   iXBRL 8-K 23166
  Complete submission text file 0001193125-23-213436.txt   148116

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA freq-20230811.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE freq-20230811_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE freq-20230811_pre.xml EX-101.PRE 11707
6 EXTRACTED XBRL INSTANCE DOCUMENT d493024d8k_htm.xml XML 3472
Mailing Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE SUITE 300 LEXINGTON MA 02421 781-315-4600
Frequency Therapeutics, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 231174878
SIC: 2834 Pharmaceutical Preparations